ECompany · Healthtech & Bio
Eclova Therapeutics
Eclova Therapeutics is a stealth-mode biotechnology company based in Barcelona, Spain, developing next-generation targeted therapeutics. It was created by, and is backed from day one by, the Barcelona-based life-sciences venture capital firm Invivo Partners as part of Invivo's company-creation strategy. The company has not yet disclosed its pipeline, funding round, or team beyond its founding CEO.
Founded
—
Founders
1
News
0
Rounds
0
Investors
1
SectorsBiotechnology, Targeted Therapeutics, Drug Development
Start-up MapHealthtech & Bio › Drug discovery & therapeutics developers
Profile updated 31 Jul 2026
Founders
N
Nicole Clarke, PhD, MBA, MSM
Founder & CEO
—
Global models 5
MModerna
United States · www.modernatx.com ↗
A venture-created (by Flagship Pioneering) targeted therapeutics/platform biotech that scaled from a stealth-stage startup, mirroring Eclova's VC-incubated origin.
$2.6BComparable
AAltos Labs
United States · altoslabs.com ↗
A stealth-launched, investor-created biotech developing next-generation therapeutics, structurally similar to Eclova's venture-creation model.
$3BComparable
XXaira Therapeutics
United States · xaira.com ↗
Launched from stealth by ARCH Venture Partners to build targeted therapeutics from inception, the same VC-founded-company playbook as Eclova/Invivo Partners.
$1B+Comparable
IInsitro
United States · insitro.com ↗
Early-stage-VC-backed company built to discover and develop targeted therapeutics, comparable in stage and therapeutic focus to Eclova.
$700M+Comparable
RRecursion Pharmaceuticals
United States · www.recursion.com ↗
VC-funded drug developer focused on discovering targeted therapeutics, a similar early-stage biotech model to Eclova before its eventual IPO.
$500M+Comparable
Investors 1
Funding rounds
No announced rounds on record.
News & media
No coverage on record yet.